{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:31:14Z","timestamp":1788348674535,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00262-012-1262-0","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T14:48:29Z","timestamp":1335019709000},"page":"2021-2031","source":"Crossref","is-referenced-by-count":35,"title":["Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy"],"prefix":"10.1007","volume":"61","author":[{"given":"Timo","family":"Buhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias J.","family":"Legler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Schardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger A.","family":"Haenssle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,22]]},"reference":[{"key":"1262_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419\u2013426","journal-title":"Nature"},{"key":"1262_CR2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","volume":"23","author":"ES Trombetta","year":"2005","unstructured":"Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975\u20131028","journal-title":"Annu Rev Immunol"},{"key":"1262_CR3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4049\/jimmunol.0902539","volume":"186","author":"K Palucka","year":"2011","unstructured":"Palucka K, Ueno H, Banchereau J (2011) Recent developments in cancer vaccines. J Immunol 186:1325\u20131331","journal-title":"J Immunol"},{"key":"1262_CR4","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMra072739","volume":"358","author":"OJ Finn","year":"2008","unstructured":"Finn OJ (2008) Cancer immunology. N Engl J Med 358:2704\u20132715","journal-title":"N Engl J Med"},{"key":"1262_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411\u2013422","journal-title":"N Engl J Med"},{"key":"1262_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.20051639","volume":"203","author":"SB Boscardin","year":"2006","unstructured":"Boscardin SB, Hafalla JC, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U et al (2006) Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 203:599\u2013606","journal-title":"J Exp Med"},{"key":"1262_CR7","doi-asserted-by":"crossref","unstructured":"Thomson AW, Robbins PD (2008) Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 67(Suppl 3):iii90\u2013iii96","DOI":"10.1136\/ard.2008.099176"},{"key":"1262_CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2796.2008.02047.x","volume":"265","author":"CR Rinaldo","year":"2009","unstructured":"Rinaldo CR (2009) Dendritic cell-based human immunodeficiency virus vaccine. J Intern Med 265:138\u2013158","journal-title":"J Intern Med"},{"key":"1262_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-1759(00)00269-6","volume":"245","author":"B Feuerstein","year":"2000","unstructured":"Feuerstein B, Berger TG, Maczek C, Roder C, Schreiner D, Hirsch U et al (2000) A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 245:15\u201329","journal-title":"J Immunol Methods"},{"key":"1262_CR10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1537-2995.2009.02519.x","volume":"50","author":"HS Garritsen","year":"2010","unstructured":"Garritsen HS, Macke L, Meyring W, Hannig H, Pagelow U, Wormann B et al (2010) Efficient generation of clinical-grade genetically modified dendritic cells for presentation of multiple tumor-associated proteins. Transfusion 50:831\u2013842","journal-title":"Transfusion"},{"key":"1262_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2004.12.014","volume":"299","author":"J John","year":"2005","unstructured":"John J, Dalgleish A, Melcher A, Pandha H (2005) Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination. J Immunol Methods 299:37\u201346","journal-title":"J Immunol Methods"},{"key":"1262_CR12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/CJI.0b013e3181a5bc13","volume":"32","author":"H Hayden","year":"2009","unstructured":"Hayden H, Friedl J, Dettke M, Sachet M, Hassler M, Dubsky P et al (2009) Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy. J Immunother 32:638\u2013654","journal-title":"J Immunother"},{"key":"1262_CR13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.124.3221.515","volume":"124","author":"HT Meryman","year":"1956","unstructured":"Meryman HT (1956) Mechanics of freezing in living cells and tissues. Science 124:515\u2013521","journal-title":"Science"},{"key":"1262_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2002-23515","volume":"20","author":"DE Pegg","year":"2002","unstructured":"Pegg DE (2002) The history and principles of cryopreservation. Semin Reprod Med 20:5\u201313","journal-title":"Semin Reprod Med"},{"key":"1262_CR15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1537-2995.2007.01212.x","volume":"47","author":"HT Meryman","year":"2007","unstructured":"Meryman HT (2007) Cryopreservation of living cells: principles and practice. Transfusion 47:935\u2013945","journal-title":"Transfusion"},{"key":"1262_CR16","first-page":"1001","volume":"83","author":"J Perez-Oteyza","year":"1998","unstructured":"Perez-Oteyza J, Bornstein R, Corral M, Hermosa V, Alegre A, Torrabadella M et al (1998) Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for cryobiology and biology of bone marrow transplantation (CBTMO), Spain. Haematologica 83:1001\u20131005","journal-title":"Haematologica"},{"key":"1262_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1537-2995.2003.00271.x","volume":"43","author":"M Montanari","year":"2003","unstructured":"Montanari M, Capelli D, Poloni A, Massidda D, Brunori M, Spitaleri L et al (2003) Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80\u00a0\u00b0C. Transfusion 43:42\u201349","journal-title":"Transfusion"},{"key":"1262_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488806775269179","volume":"1","author":"AM Bakken","year":"2006","unstructured":"Bakken AM (2006) Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 1:47\u201354","journal-title":"Curr Stem Cell Res Ther"},{"key":"1262_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1423-0410.2005.00562.x","volume":"88","author":"CE Wolf","year":"2005","unstructured":"Wolf CE, Meyer M, Riggert J (2005) Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: product quality and prediction of the yield using different harvest procedures. Vox Sang 88:249\u2013255","journal-title":"Vox Sang"},{"key":"1262_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0625.2007.00668.x","volume":"17","author":"H Haenssle","year":"2008","unstructured":"Haenssle H, Buhl T, Knudsen S, Krueger U, Rosenberger A, Reich K et al (2008) CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes. Exp Dermatol 17:177\u2013187","journal-title":"Exp Dermatol"},{"key":"1262_CR21","volume-title":"Nonparametric analysis of longitudinal data in factorial experiments","author":"E Brunner","year":"2002","unstructured":"Brunner E, Domhof S, Langer F (2002) Nonparametric analysis of longitudinal data in factorial experiments. Wiley, New York"},{"key":"1262_CR22","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-08-2729","volume":"15","author":"P Verdijk","year":"2009","unstructured":"Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM et al (2009) Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 15:2531\u20132540","journal-title":"Clin Cancer Res"},{"key":"1262_CR23","doi-asserted-by":"crossref","first-page":"e18801","DOI":"10.1371\/journal.pone.0018801","volume":"6","author":"A Draube","year":"2011","unstructured":"Draube A, Klein-Gonzalez N, Mattheus S, Brillant C, Hellmich M, Engert A et al (2011) Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis. PLoS ONE 6:e18801","journal-title":"PLoS ONE"},{"key":"1262_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-008-0568-4","volume":"58","author":"L Engell-Noerregaard","year":"2009","unstructured":"Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM (2009) Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother 58:1\u201314","journal-title":"Cancer Immunol Immunother"},{"key":"1262_CR25","first-page":"5091","volume":"30","author":"WJ Lesterhuis","year":"2010","unstructured":"Lesterhuis WJ, De Vries IJ, Schreibelt G, Schuurhuis DH, Aarntzen EH, De Boer A et al (2010) Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res 30:5091\u20135097","journal-title":"Anticancer Res"},{"key":"1262_CR26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","volume":"17","author":"D Schadendorf","year":"2006","unstructured":"Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Brocker EB et al (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 17:563\u2013570","journal-title":"Ann Oncol"},{"key":"1262_CR27","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-09-1254","volume":"15","author":"A Ribas","year":"2009","unstructured":"Ribas A, Comin-Anduix B, Chmielowski B, Jalil J, de la Rocha P, McCannel TA et al (2009) Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res 15:6267\u20136276","journal-title":"Clin Cancer Res"},{"key":"1262_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CJI.0b013e3181facf48","volume":"34","author":"C Rollig","year":"2011","unstructured":"Rollig C, Schmidt C, Bornhauser M, Ehninger G, Schmitz M, Auffermann-Gretzinger S (2011) Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells. J Immunother 34:100\u2013106","journal-title":"J Immunother"},{"key":"1262_CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2141.2010.08286.x","volume":"150","author":"Q Yi","year":"2010","unstructured":"Yi Q, Szmania S, Freeman J, Qian J, Rosen NA, Viswamitra S et al (2010) Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients. Br J Haematol 150:554\u2013564","journal-title":"Br J Haematol"},{"key":"1262_CR30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00262-007-0334-z","volume":"56","author":"S Tuyaerts","year":"2007","unstructured":"Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K et al (2007) Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother 56:1513\u20131537","journal-title":"Cancer Immunol Immunother"},{"key":"1262_CR31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1381612023396023","volume":"8","author":"S Vuckovic","year":"2002","unstructured":"Vuckovic S, Clark GJ, Hart DN (2002) Growth factors, cytokines and dendritic cell development. Curr Pharm Des 8:405\u2013418","journal-title":"Curr Pharm Des"},{"key":"1262_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/146532401753277184","volume":"3","author":"Y Suen","year":"2001","unstructured":"Suen Y, Lee SM, Aono F, Hou S, Loudovaris M, Ofstein G et al (2001) Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy 3:365\u2013375","journal-title":"Cytotherapy"},{"key":"1262_CR33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14653240310003053","volume":"5","author":"T Felzmann","year":"2003","unstructured":"Felzmann T, Witt V, Wimmer D, Ressmann G, Wagner D, Paul P et al (2003) Monocyte enrichment from leukapheresis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy 5:391\u2013398","journal-title":"Cytotherapy"},{"key":"1262_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/152581603322023025","volume":"12","author":"F Meyer-Wentrup","year":"2003","unstructured":"Meyer-Wentrup F, Burdach S (2003) Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations. J Hematother Stem Cell Res 12:289\u2013299","journal-title":"J Hematother Stem Cell Res"},{"key":"1262_CR35","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1537-2995.2008.01756.x","volume":"48","author":"P Perseghin","year":"2008","unstructured":"Perseghin P, D\u2019Amico G, Dander E, Gaipa G, Dassi M, Biagi E et al (2008) Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device. Transfusion 48:1644\u20131649","journal-title":"Transfusion"},{"key":"1262_CR36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/104303404323142015","volume":"15","author":"K Breckpot","year":"2004","unstructured":"Breckpot K, Corthals J, Heirman C, Bonehill A, Michiels A, Tuyaerts S et al (2004) Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15:562\u2013573","journal-title":"Hum Gene Ther"},{"key":"1262_CR37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2567.2004.02076.x","volume":"114","author":"E Elkord","year":"2005","unstructured":"Elkord E, Williams PE, Kynaston H, Rowbottom AW (2005) Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 114:204\u2013212","journal-title":"Immunology"},{"key":"1262_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cryobiol.2008.12.006","volume":"58","author":"YJ Heo","year":"2009","unstructured":"Heo YJ, Son CH, Chung JS, Park YS, Son JH (2009) The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy. Cryobiology 58:203\u2013209","journal-title":"Cryobiology"},{"key":"1262_CR39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.175.6.1789","volume":"175","author":"O Spertini","year":"1992","unstructured":"Spertini O, Luscinskas FW, Gimbrone MA Jr, Tedder TF (1992) Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions. J Exp Med 175:1789\u20131792","journal-title":"J Exp Med"},{"key":"1262_CR40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1701495","volume":"22","author":"F Boer De","year":"1998","unstructured":"De Boer F, Drager AM, Van der Wall E, Pinedo HM, Schuurhuis GJ (1998) Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants. Bone Marrow Transpl 22:1103\u20131110","journal-title":"Bone Marrow Transpl"},{"key":"1262_CR41","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00342-08","volume":"16","author":"A Weinberg","year":"2009","unstructured":"Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R et al (2009) Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 16:1176\u20131186","journal-title":"Clin Vaccine Immunol"},{"key":"1262_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CDLI.6.1.14-19.1999","volume":"6","author":"CA Kleeberger","year":"1999","unstructured":"Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV (1999) Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12\u00a0years in a multicenter study. Clin Diagn Lab Immunol 6:14\u201319","journal-title":"Clin Diagn Lab Immunol"},{"key":"1262_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0625.2009.00954.x","volume":"19","author":"HA Haenssle","year":"2010","unstructured":"Haenssle HA, Riedl P, Buhl T, Schardt A, Rosenberger A, Sch\u00f6n MP et al (2010) Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide\/poly(I:C) complexes efficiently activate T cells. Exp Dermatol 19:19\u201328","journal-title":"Exp Dermatol"},{"key":"1262_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.immuni.2008.08.006","volume":"29","author":"D Alvarez","year":"2008","unstructured":"Alvarez D, Vollmann EH, von Andrian UH (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29:325\u2013342","journal-title":"Immunity"},{"key":"1262_CR45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00262-002-0355-6","volume":"52","author":"J Westermann","year":"2003","unstructured":"Westermann J, Korner IJ, Kopp J, Kurz S, Zenke M, Dorken B et al (2003) Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties. Cancer Immunol Immunother 52:194\u2013198","journal-title":"Cancer Immunol Immunother"},{"key":"1262_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00002371-200401000-00003","volume":"27","author":"S Hori","year":"2004","unstructured":"Hori S, Heike Y, Takei M, Maruyama M, Inoue Y, Lee JJ et al (2004) Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes. J Immunother 27:27\u201335","journal-title":"J Immunother"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00262-012-1262-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:54:55Z","timestamp":1594018495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,22]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1262-0","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,22]]}}}